Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biweekly Docetaxel and S-1 in Advanced Gastric Cancer
NCT03137004Phase 2Unknown
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Jun 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, tegafur in gastric cancer (GC), sponsored by Fujian Medical University Cancer Hospital. Status: unknown.
02
Drugs
docetaxeltegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03137004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03137004.